Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) FCF Margin (2016 - 2025)

Historic FCF Margin for Traws Pharma (TRAW) over the last 14 years, with Q2 2025 value amounting to 218.77%.

  • Traws Pharma's FCF Margin rose 170654400.0% to 218.77% in Q2 2025 from the same period last year, while for Sep 2025 it was 684.01%, marking a year-over-year increase of 126708500.0%. This contributed to the annual value of 14796.46% for FY2024, which is 68557500.0% down from last year.
  • According to the latest figures from Q2 2025, Traws Pharma's FCF Margin is 218.77%, which was up 170654400.0% from 9538.6% recorded in Q1 2025.
  • In the past 5 years, Traws Pharma's FCF Margin ranged from a high of 218.77% in Q2 2025 and a low of 20133.33% during Q3 2024
  • Its 5-year average for FCF Margin is 8744.54%, with a median of 7755.89% in 2022.
  • Per our database at Business Quant, Traws Pharma's FCF Margin crashed by -122929800bps in 2024 and then surged by 170654400bps in 2025.
  • Quarter analysis of 5 years shows Traws Pharma's FCF Margin stood at 7616.07% in 2021, then grew by 9bps to 6935.71% in 2022, then dropped by -14bps to 7910.71% in 2023, then rose by 9bps to 7214.29% in 2024, then skyrocketed by 97bps to 218.77% in 2025.
  • Its last three reported values are 218.77% in Q2 2025, 9538.6% for Q1 2025, and 7214.29% during Q4 2024.